HNW
LMAT icon

High Note Wealth’s LeMaitre Vascular LMAT Stock Holding History

High Note Wealth’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14
Closed -$1.18K – 948
2025
Q1 		$1.18K Buy
+14
New +$1.3K ﹤0.01% 740

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

High Note Wealth's LMAT Position: Q2 2025 in Review

High Note Wealth sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 14 shares — an estimated $1.18K sold.

High Note Wealth first reported a position in LMAT in Q1 2025 and held it in 1 quarter. The position peaked at $1.18K in Q1 2025. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • High Note Wealth reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
  • High Note Wealth sold 14 LeMaitre Vascular shares in Q2 2025, an estimated $1.18K.
  • High Note Wealth first reported a position in LeMaitre Vascular in Q1 2025 and held it in 1 quarter.
  • High Note Wealth's LeMaitre Vascular position peaked at $1.18K in Q1 2025.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on High Note Wealth's 13F filing for Q2 2025, filed 23 Jul 2025.